It has been suggested that simvastatin limits the progression of apical periodontitis, possibly by diminishing Cyr61 expression in osteoblasts and, subsequently, by reducing macrophage chemotaxis into the lesions [53]. This evidence concerns the gene CCN1 and periapical periodontitis.